HEPION PHARMACEUTICALS INC's ticker is HEPA and the CUSIP is 426897104. A total of 32 filers reported holding HEPION PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.11 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $1,244,552 | +159.4% | 1,602,772 | +0.3% | 0.00% | – |
Q4 2022 | $479,748 | -40.4% | 1,597,566 | +0.3% | 0.00% | – |
Q3 2022 | $805,000 | -12.9% | 1,592,781 | -1.4% | 0.00% | – |
Q2 2022 | $924,000 | -55.6% | 1,614,716 | +0.1% | 0.00% | – |
Q1 2022 | $2,080,000 | +12.4% | 1,612,627 | -0.7% | 0.00% | – |
Q4 2021 | $1,850,000 | -26.0% | 1,623,905 | -0.6% | 0.00% | – |
Q3 2021 | $2,500,000 | -23.5% | 1,634,012 | -1.0% | 0.00% | – |
Q2 2021 | $3,266,000 | +3.4% | 1,649,929 | -3.9% | 0.00% | – |
Q1 2021 | $3,158,000 | +20.7% | 1,716,168 | +43.7% | 0.00% | – |
Q4 2020 | $2,616,000 | +1284.1% | 1,194,434 | +1867.1% | 0.00% | – |
Q3 2020 | $189,000 | +9.2% | 60,722 | 0.0% | 0.00% | – |
Q2 2020 | $173,000 | +61.7% | 60,722 | 0.0% | 0.00% | – |
Q1 2020 | $107,000 | -67.1% | 60,722 | 0.0% | 0.00% | – |
Q4 2019 | $325,000 | – | 60,722 | +57184.9% | 0.00% | – |
Q3 2019 | $0 | – | 106 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SABBY MANAGEMENT, LLC | 57,309 | $178,000 | 0.03% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 15,552 | $48,000 | 0.00% |
Squarepoint Ops LLC | 15,524 | $48,000 | 0.00% |
ExodusPoint Capital Management, LP | 11,632 | $36,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 33,215 | $103,000 | 0.00% |
WELLS FARGO & COMPANY/MN | 57 | $0 | 0.00% |
CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 15,786 | $49,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 29,233 | $91,000 | 0.00% |
MORGAN STANLEY | 54 | $0 | 0.00% |